2,7-Dichlorobenzo[d]thiazole → HCID 44158821, compound
Reaction equation
F[C:2]1[CH:28]=[CH:27][C:5]2[N:6]=[C:7]([C:9]3[C:10]([NH2:26])=[N:11][CH:12]=[C:13]([C:15]4[CH:16]=[N:17][N:18]([CH:20]5[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]5)[CH:19]=4)[CH:14]=3)[S:8][C:4]=2[CH:3]=1.[Cl:29]C1SC2C(Cl)=CC=CC=2N=1>>[Cl:29][C:3]1[C:4]2[S:8][C:7]([C:9]3[C:10]([NH2:26])=[N:11][CH:12]=[C:13]([C:15]4[CH:16]=[N:17][N:18]([CH:20]5[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]5)[CH:19]=4)[CH:14]=3)=[N:6][C:5]=2[CH:27]=[CH:28][CH:2]=1Participants
3
Procedure
Same procedure as 3-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine except using 2,7-dichloro-1,3-benzothiazole in place of 2-chloro-6-fluorobenzothiazole to afford the title compound as a yellow solid. 1H NMR (400 MHz, DMSO-d6): δ=2.10-2.22 (m, 2H), 2.23-2.31 (m, 2H), 3.12 (q, J=11.1 Hz, 2H), 3.42 (d, J=12.4 Hz, 2H), 4.46-4.56 (m, 1H), 7.60-7.66 (m, 2H), 8.09 (s, 1H), 8.12 (dd, J=6.2, 2.9 Hz, 1H), 8.44 (s, 2H), 8.56 (d, J=1.8 Hz, 1H). MS (ES+): m/z=411.09/413.06 (3:1) [MH+]. HPLC: tR=2.16 min (ZQ2, polar—5 min).
Sources & evidence
- ORD record
- ord-3bfa16f62dbe48c6bda4129201cecb07
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08178668B2
Reaction notes
Loading…